Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Neurooncol. 2017 Jan 23;132(1):181–188. doi: 10.1007/s11060-016-2357-9

Table 1. Patient Characteristics.

ARM 1 ARM 2 ARM 3
Number of patients 21 20 18
 DL0 (2mg/kg) 3 4 3
 DL1 (4mg/kg) 18 16 15
Men/Women 8/13 14/6 15/3
Glioblastoma 100% 75% 72%
Anaplastic Glioma 0% 25% 28%
Median Age (years, range) 58 (44-69) 56 (24-69) 56 (29-65)
Median KPS 90 (70-100) 80 (60-100) 90 (70-100)
Median no. of cycles (range) 5 (1-14) 4 (1-15) 5.5 (1-16)

DL: Dose level